ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	7/93	30/7206	7.58895559375e-08
ko04380	Osteoclast differentiation	12/93	134/7206	1.2040429873e-07
ko05152	Tuberculosis	13/93	187/7206	6.7324004492e-07
ko05164	Influenza A	12/93	167/7206	1.32312885322e-06
ko04620	Toll-like receptor signaling pathway	9/93	100/7206	4.86945410118e-06
ko04060	Cytokine-cytokine receptor interaction	12/93	191/7206	5.42003461297e-06
ko04612	Antigen processing and presentation	8/93	77/7206	5.76250255483e-06
ko04672	Intestinal immune network for IgA production	6/93	37/7206	6.61603016773e-06
ko05168	Herpes simplex infection	11/93	182/7206	1.98450110572e-05
ko04650	Natural killer cell mediated cytotoxicity	8/93	97/7206	3.20580424689e-05
ko05150	Staphylococcus aureus infection	5/93	36/7206	8.83038100107e-05
ko05133	Pertussis	7/93	87/7206	0.000119875553308
ko05160	Hepatitis C	9/93	153/7206	0.000145657852133
ko05162	Measles	8/93	120/7206	0.000146306615207
ko04660	T cell receptor signaling pathway	8/93	124/7206	0.000183788645642
ko05330	Allograft rejection	4/93	24/7206	0.000226707083146
ko04062	Chemokine signaling pathway	10/93	201/7206	0.000245266015214
ko05144	Malaria	5/93	45/7206	0.000261149538366
ko05161	Hepatitis B	9/93	173/7206	0.000366471399825
ko04217	Necroptosis	9/93	178/7206	0.000451963284127
ko05320	Autoimmune thyroid disease	4/93	29/7206	0.00048233846882
ko04210	Apoptosis	9/93	180/7206	0.000490471983689
ko04610	Complement and coagulation cascades	6/93	79/7206	0.000512147985426
ko05416	Viral myocarditis	5/93	55/7206	0.000671825318797
ko05321	Inflammatory bowel disease (IBD)	5/93	56/7206	0.000730251120856
ko05167	Kaposi's sarcoma-associated herpesvirus infection	9/93	191/7206	0.000753702004654
ko04621	NOD-like receptor signaling pathway	8/93	157/7206	0.000901310714894
ko05323	Rheumatoid arthritis	6/93	89/7206	0.000965756009424
ko05145	Toxoplasmosis	7/93	126/7206	0.00115278947085
ko05310	Asthma	3/93	17/7206	0.00124128043553
ko04514	Cell adhesion molecules (CAMs)	7/93	130/7206	0.00138345713136
ko04630	Jak-STAT signaling pathway	7/93	132/7206	0.00151158375332
ko05140	Leishmaniasis	5/93	75/7206	0.00272273058029
ko05166	HTLV-I infection	10/93	292/7206	0.00421253055518
ko04668	TNF signaling pathway	6/93	120/7206	0.00441357731593
ko04145	Phagosome	7/93	162/7206	0.00478338976911
ko05142	Chagas disease (American trypanosomiasis)	6/93	130/7206	0.00650366773129
ko04064	NF-kappa B signaling pathway	5/93	96/7206	0.00780535714571
ko04622	RIG-I-like receptor signaling pathway	4/93	62/7206	0.00819780682202
ko05132	Salmonella infection	5/93	98/7206	0.00849967371481
ko04664	Fc epsilon RI signaling pathway	4/93	77/7206	0.0171899536858
ko04071	Sphingolipid signaling pathway	6/93	162/7206	0.0179831512511
ko04666	Fc gamma R-mediated phagocytosis	5/93	122/7206	0.0204074178382
ko04137	Mitophagy - animal	4/93	82/7206	0.0211678892367
ko05212	Pancreatic cancer	4/93	83/7206	0.0220257380658
ko05332	Graft-versus-host disease	2/93	18/7206	0.0220443867482
ko04917	Prolactin signaling pathway	4/93	87/7206	0.0256687187936
ko00120	Primary bile acid biosynthesis	2/93	20/7206	0.0269236133468
ko04933	AGE-RAGE signaling pathway in diabetic complications	5/93	135/7206	0.0299910578909
ko05146	Amoebiasis	4/93	99/7206	0.0386753189608
ko04072	Phospholipase D signaling pathway	6/93	197/7206	0.0414705596633
ko04142	Lysosome	5/93	151/7206	0.0451699134862
ko04670	Leukocyte transendothelial migration	5/93	151/7206	0.0451699134862
ko05322	Systemic lupus erythematosus	5/93	151/7206	0.0451699134862
ko05221	Acute myeloid leukemia	3/93	63/7206	0.0474236435263
ko04659	Th17 cell differentiation	4/93	106/7206	0.047725971818